Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.
Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types.
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.

Pages